Best Peptide Protocols
    Sexual HealthSingle

    PT-141 30mg / 30mL Nasal Spray: Dosage & Research Protocol Guide

    Dosing ranges, administration details, cycle length, and storage guidance for PT-141 (Spray) 30 mg / 30 ml.

    Strength & Form:10 mg Vial30 mg / 30 ml Spray
    PT-141 (Spray) 30 mg / 30 ml peptide vial

    PT-141 (Spray) 30 mg / 30 ml

    30 mg / 30 ml Research Peptide

    Shop on ResearchLabs

    Quick Facts

    Type
    Single
    Category
    Sexual Health
    Vial Strength
    30 mg / 30 ml
    Status
    Research

    Research Purposes Only

    This information is provided for educational purposes only. This content is not intended to diagnose, treat, cure, or prevent any disease. Always consult with qualified healthcare professionals.

    Download Guide

    Save the complete PT-141 30mg / 30mL Nasal Spray research guide as a PDF.

    Educational and research use only. Not medical advice.

    Reference

    Sources used for this guide are listed in our research database .

    What Is PT-141 30mg / 30mL Nasal Spray?

    PT-141 30mg / 30mL Nasal Spray Nasal Spray Overview

    PT-141 (Bremelanotide) Nasal Spray delivers this melanocortin receptor agonist via intranasal administration. The 30 mg / 30 ml format enables non-invasive dosing for sexual health research. Nasal delivery provides rapid absorption and CNS access, targeting MC3R/MC4R receptors in the brain's arousal pathways.

    PT-141 30mg / 30mL Nasal Spray Quick Reference

    PT-141 30mg / 30mL Nasal Spray Nasal Spray Specifications

    Peptide
    PT-141 (Spray) 30 mg / 30 ml (NNMT inhibitor)
    Vial Content
    30 mg PT-141 in 30 ml nasal spray
    Category
    Sexual Health
    Administration Method
    Intranasal spray
    Common Use Case
    Sexual health research via non-invasive nasal delivery

    PT-141 30mg / 30mL Nasal Spray Compared With Other Formats

    Details that distinguish this 30 mg / 30 ml format include:

    • No injection required
    • Rapid CNS access for central arousal pathways
    • Convenient on-demand dosing
    • Direct melanocortin receptor targeting

    How Does PT-141 Work?

    PT-141 Mechanism of Action

    PT-141 (Bremelanotide) delivered intranasally activates MC3R and MC4R receptors in the CNS to modulate sexual arousal through brain pathways rather than peripheral blood flow mechanisms.

    What Are the Potential Benefits of PT-141?

    PT-141 Research Findings and Observed Outcomes

    Findings and reported areas of study for PT-141 (Spray) 30 mg / 30 ml include:

    • Central arousal pathway activation
    • Non-invasive delivery
    • Rapid onset via nasal mucosa
    • Both male and female research applications

    These observations are discussed for research and educational reference only and are not medical claims.

    What Do You Need to Use PT-141 30mg / 30mL Nasal Spray?

    PT-141 30mg / 30mL Nasal Spray Supplies for Use and Handling

    • •PT-141 Nasal Spray bottle

    Supplies listed are for laboratory handling and research preparation purposes only.

    PT-141 30mg / 30mL Nasal Spray Administration and Research Protocol

    PT-141 Nasal Route, Frequency and Timing

    RouteIntranasal
    FrequencyAs needed, max 1x per 24 hours
    Timing30–60 minutes before desired effect

    Do not exceed once per 24 hours.

    PT-141 30mg / 30mL Nasal Spray Dosage Guide

    PT-141 Dosage Ranges

    The ranges below pair the listed dose with the draw volume for this product strength.

    Low Range1 spray (100 mcg) as needed
    Standard Range2–3 sprays (200–300 mcg) as needed
    Upper Range5 sprays (500 mcg) as needed

    PT-141 30mg / 30mL Nasal Spray Dosage Examples

    Based on reconstitution below

    Target Daily DoseDraw VolumeUnits
    100 mcg1 sprayPer nostril
    200 mcg2 spraysPer nostril

    This dosing table is unique to the 30 mg / 30 ml vial. Units refer to markings on a standard U-100 insulin syringe (1 unit = 0.01 mL).

    How Long Does PT-141 30mg / 30mL Nasal Spray Last?

    PT-141 30mg / 30mL Nasal Spray Duration by Research Dose

    At common research doses, one 30 mg / 30 ml vial of PT-141 typically supports:

    1 spray (100 mcg) as neededAs needed
    2–3 sprays (200–300 mcg) as neededAs needed
    5 sprays (500 mcg) as neededAs needed, limit to 2–3x/week

    PT-141 30mg / 30mL Nasal Spray Preparation and Handling

    PT-141 30mg / 30mL Nasal Spray Use and Handling Instructions

    This section applies specifically to the PT-141 (Spray) 30 mg / 30 ml.

    Recommended Diluent
    Pre-mixed
    Diluent Volume
    30 ml
    Final Concentration
    1 mg/ml

    PT-141 30mg / 30mL Nasal Spray Preparation Steps

    1. 1Remove the vial from storage and allow it to reach room temperature (10–15 minutes).
    2. 2Wash hands thoroughly and prepare a clean workspace with all supplies.
    3. 3Using a sterile syringe, draw the appropriate volume of bacteriostatic water.
    4. 4Clean the rubber stopper of the vial with an alcohol prep pad.
    5. 5Insert the needle at a slight angle and slowly inject the diluent down the inner wall of the vial.
    6. 6Gently swirl or roll the vial until fully dissolved; the solution should appear clear and colorless.
    7. 7Label the vial with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light. Use within 2–4 weeks.

    PT-141 Stacks and Research Combinations

    PT-141 and Compatible Research Pairings

    In research settings, PT-141 (Spray) 30 mg / 30 ml is sometimes paired with peptides such as:

    • Oxytocin: Complementary bonding and arousal pathways

    Factors That May Affect PT-141 Research Outcomes

    Supporting Factors for PT-141 Research

    Factors recorded alongside this protocol include:

    • Use on an empty stomach for best absorption
    • Avoid alcohol

    These factors can affect how research observations are interpreted.

    PT-141 Side Effects and Safety Considerations

    PT-141 30mg / 30mL Nasal Spray Tolerability Notes

    Generally well-tolerated

    Some individuals report:

    • Nausea (most common)
    • Flushing
    • Nasal congestion
    • Headache

    How to Store PT-141 Before and After Opening

    PT-141 30mg / 30mL Nasal Spray Storage Requirements

    Unreconstituted
    N/A — pre-mixed
    Reconstituted
    Refrigerate (2–8°C)
    Post-Mix Stability
    Use within 30 days of opening

    Who Should Avoid PT-141?

    This peptide is generally not recommended for:

    • Those with uncontrolled hypertension
    • Pregnant or breastfeeding individuals
    • Those with cardiovascular conditions

    PT-141 30mg / 30mL Nasal Spray FAQs

    How quickly does nasal PT-141 take effect?

    Intranasal PT-141 typically shows effects within 30–60 minutes, similar to or faster than subcutaneous injection.

    Where to Buy PT-141 30mg / 30mL Nasal Spray for Research

    PT-141 30mg / 30mL Nasal Spray Purchasing and Research Supply Notes

    Before ordering PT-141 (Spray) 30 mg / 30 ml, review the product label, available testing documents, and storage instructions.

    Check the ResearchLabs listing for:

    • Available testing documents
    • Product strength and concentration
    • Storage and handling instructions
    • Current product availability

    View the current listing for PT-141 (Spray) 30 mg / 30 ml:

    → View on ResearchLabs

    Confirm the product strength and storage requirements before ordering. Products are for laboratory research only and are not for human consumption.

    Related Sexual Health Peptides

    Oxytocin (5 mg Vial) productOxytocin (5 mg Vial)PT-141 (10 mg Vial) productPT-141 (10 mg Vial)Melanotan I (10 mg Vial) productMelanotan I (10 mg Vial)Melanotan II (10 mg Vial) productMelanotan II (10 mg Vial)